(Q83855416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

embryonal rhabdomyosarcoma

28 January 2020

main subject

1 reference

10

Joseph D Khoury

0 references

author name string

Ramapriya Ganti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Stephen X Skapek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jie Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Christine E Fuller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jianrong Wu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Catherine A Billups

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Philip P Breitfeld

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

James D Dalton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

William H Meyer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

26 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1213-1220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16729016%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.3800636

28 January 2020

exact match

0 references

cites work

Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Intergroup Rhabdomyosarcoma Study: update for pathologists.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

ErbB receptors: directing key signaling networks throughout life

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Genetic pathways to glioblastoma: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

The ErbB/HER receptor protein-tyrosine kinases and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Human EGFR, a candidate gene for the Silver-Russell syndrome, is biallelically expressed in a wide range of fetal tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Immunolocalization of Epidermal Growth Factor Receptors in Normal Developing Human Skin

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

ErbB2 is required for muscle spindle and myoblast cell survival.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

STAT3 is activated in a subset of the Ewing sarcoma family of tumours.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Targeting epidermal growth factor receptor--are we missing the mark?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Gene expression profiling of human sarcomas: insights into sarcoma biology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021

EGF mutant receptor vIII as a molecular target in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800636

7 January 2021